MSC therapy for diabetic kidney disease and nephrotic syndrome

Nat Rev Nephrol. 2023 Dec;19(12):754-755. doi: 10.1038/s41581-023-00776-z.

Authors

Bo Lu^{1

2}, Lilach O Lerman³

Affiliations

¹ Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
² Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
³ Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA. Lerman.Lilach@mayo.edu.

PMID: 37783947
DOI: 10.1038/s41581-023-00776-z

No abstract available

MeSH terms

Diabetes Mellitus*
Diabetic Nephropathies* / therapy
Humans
Kidney
Nephrotic Syndrome* / complications
Nephrotic Syndrome* / therapy